Approximately 2 to 6% of gastric cancers produce AFP, and these are generally associated with high rates of venous invasion, lymph node metastasis and liver metastasis, and an extremely poor survival rate, compared with other gastric cancers [29]. This evidence concerns the gene AFP and metastatic malignant neoplasm in the lymph nodes.